Islet transplantation in type 1 diabetes mellitus;Inseltransplantation bei typ 1 diabetes mellitus

Therapeutische Umschau

Volumn 62, Issue 7, 2005, Pages 481-486

  Lehmann, Roger ^a   Pavlicek, V ^a   Spinas, G A ^a   Weber, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GLUCOSE MONITORING; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY FAILURE; ORGAN DONOR; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; REVIEW; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; CLINICAL PRACTICE; EUROPE; GRAFT REJECTION; METHODOLOGY; NORTH AMERICA; PRACTICE GUIDELINE; RISK ASSESSMENT; SWITZERLAND; TRANSPLANTATION;

DIABETES MELLITUS, TYPE 1; EUROPE; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; NORTH AMERICA; PANCREAS TRANSPLANTATION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; SWITZERLAND; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 22344431956     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.62.7.481     Document Type: Review

References (19)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-86.
2. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 2817-23.
3. Gruessner RW, Sutherland DE, Troppmann C, Benedetti E, Hakim N, Dunn DL, Gruessner AC. The surgical risk of pancreas transplantation in the cyclosporine era: an overview [see comments]. J Am Coll Surg 1997; 185: 128-44.
4. Shapiro JA, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-8.
5. Lehmann R, Weber M, Berthold P, Zuellig R, Pfammatter T, Maedler K, Donath MY, Ambuehl P, Demartines N, Clavien PA, Spinas GA. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: Two-year follow-up. Am J Transplant 2004; 4: 1117-23.
6. Fiorina P, Folli F, Bertuzzi F, Maffi P, Finzi G, Venturini M, Socci C, Davalli AM, Orsenigo E, Falqui L, Uccella S, La Rosa S, Usellini L, Properzi G, Di Carlo V, Del Maschio A, Capella C, Secchi A. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003; 26: 1129-36.
7. Johansson BL, Borg K, Fernquist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000; 17: 181-9.
8. Ricordi C, Strom TB. Clinical islet transplantation: Advances and immunological challenges. Nat Immunol 2004; 4: 259-68.
9. Robertson RP, Davis C, Larsen J, Stratton R, Sutherland DE. Pancreas and islet transplantation für patients with diabetes: Technical review. Diabetes Care 2000; 23: 112-6.
10. Robertson RP. Islet transplantation as a treatment for diabetes - work in progress. New England Journal of Medicine 2004; 350: 694-705.
11. Wiseman AC, Gill RG. Current status of clinical islet transplantation: Advances and obstacles. Curr Opin Endocrinol Diabetes 2004; 11: 98-103.
12. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004; 114: 877-83.
13. Shapiro AMJ, Lakey JR, Paty BW, Senior P, McDonald C, McCready T, Oberholzer J, Kneteman N, Rajotte RV, Bigam D, O'Kelly K, Ryan EA. Clinical islet transplantation in Edmonton - 3-year outcomes and new developments (Abstract). Diabetes 2003; 52: Suppl. 1.
14. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL. {beta}-Cell Function Following Human Islet Transplantation for Type 1 Diabetes. Diabetes 2005; 54: 100-6.
15. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148-57.
16. Maedler K, Spinas GA, Lehmann R, Sergeev P, Weber M, Fontana A, Kaiser N, Donath MY. Glucose induces beta-cell apoptosis via upregulation of the Fas receptor in human islets. Diabetes 2001; 50: 1683-90.
17. Sakai K, Matsumoto K, Nishikawa T, Suefuji M, Nakamaru K, Hirashima Y, Kawashima J, Shirotani T, Ichinose K, Brownlee M, Araki E. Mitochondrial reactive oxygen species reduce insulin secretion by pancreatic beta-cells. Biochem Biophys Res Commun 2003; 300: 216-22.
18. Ceriello A. Postprandial Hyperglycemia and Diabetes Complications: Is It Time to Treat? Diabetes 2005; 54: 1-7.
19. Hirshberg B, Rother KI, Digon III BJ, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ, Harlan DM. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression. The National Institutes of Health experience. Diabetes Care 2003; 26: 3288-95.